Successful implantation of a left ventricular assist device in a patient with heparin-induced thrombocytopenia and thrombosis

J Extra Corpor Technol. 2014 Jun;46(2):162-5.

Abstract

We report the case of a 27-year-old woman with signs of heparin-induced thrombocytopenia and thrombosis (HITT) and left heart failure presenting for urgent implantation of a left ventricular assist device (LVAD). HITT can occur in 4.2-6.1% of patients with LVADs. If the patient remains hemodynamically stable, implantation can be delayed for several months until the heparin/PF-4 antibodies decline allowing the use of heparin on cardiopulmonary bypass, However, in most cases related to cardiogenic shock, surgery cannot be delayed. We present the case of a patient who underwent implantation of a HeartMate II LVAD and discuss management strategy using bivalirudin during cardiopulmonary bypass.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Antithrombins / therapeutic use
  • Cardiopulmonary Bypass / methods
  • Combined Modality Therapy
  • Female
  • Heart Diseases / chemically induced*
  • Heart Diseases / diagnosis
  • Heart Diseases / therapy*
  • Heart Ventricles / surgery
  • Heart-Assist Devices
  • Heparin / adverse effects*
  • Heparin / therapeutic use
  • Hirudins
  • Humans
  • Peptide Fragments / therapeutic use
  • Prosthesis Implantation / methods
  • Recombinant Proteins / therapeutic use
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / therapy*
  • Thrombosis / chemically induced*
  • Thrombosis / diagnosis
  • Thrombosis / therapy*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Antithrombins
  • Hirudins
  • Peptide Fragments
  • Recombinant Proteins
  • Heparin
  • bivalirudin